Cluster clearing agents (CCAs) and the use thereof are discussed. CCAs are
composed of a hepatic clearance directing moiety which directs the biodistribution
of a CCA-containing construct to hepatic clearance; and a binding moiety which
mediates binding of the CCA to a compound for which rapid hepatic clearance is desired.
